Review
Nature Reviews Drug Discovery 2, 123-131 (February 2003) | doi:10.1038/nrd1007
Molecular imaging in drug discovery and development
Markus Rudin1 & Ralph Weissleder2 About the authors
Abstract
Imaging sciences have grown exponentially during the past three decades, and many techniques, such as magnetic resonance imaging, nuclear tomographic imaging and X-ray computed tomography, have become indispensable in clinical use. Advances in imaging technologies and imaging probes for humans and for small animals are now extending the applications of imaging further into drug discovery and development, and have the potential to considerably accelerate the process. This review summarizes some of the recent developments in conventional and molecular imaging, and highlights their impact on drug discovery.
- View At a Glance
Author affiliations
- Novartis Institute for Biomedical Research, CH-4002 Basel, Switzerland.
- Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Boston, Charlestown, Massachusetts 02129, USA.
Correspondence to: Ralph Weissleder2 Email: weissleder@helix.mgh.harvard.edu
